Changeflow GovPing Healthcare & Life Sciences FDA Acknowledges Letter from 3 Foot World
Routine Notice Added Final

FDA Acknowledges Letter from 3 Foot World

Email

Summary

The FDA has acknowledged receipt of a letter from 3 Foot World regarding a matter associated with docket FDA-2026-V-1589. The agency has provided a link to the acknowledgment letter, which was authored by CDRH.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The Food and Drug Administration (FDA) has issued a notice acknowledging receipt of a letter from an entity named 3 Foot World. This acknowledgment is associated with docket number FDA-2026-V-1589. The document itself is an acknowledgment letter from the FDA's CDRH (Center for Devices and Radiological Health) to 3 Foot World, indicating that the agency has received their correspondence.

This notice serves as a procedural update, confirming the FDA's receipt of communication. There are no new compliance obligations or deadlines imposed on regulated entities as a result of this acknowledgment. Compliance officers should note this communication for their records related to docket FDA-2026-V-1589, but no immediate action is required.

Archived snapshot

Mar 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Acknowledgment Letter from FDA DMB to 3 Foot World

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-V-1589-0002
Docket
FDA-2026-V-1589

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Regulatory Submissions
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11
Topics
Medical Devices

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!